BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33307595)

  • 21. Differentiating malignant and benign focal liver lesions in children using CEUS LI-RADS combined with serum alpha-fetoprotein.
    Jiang ZP; Zeng KY; Huang JY; Yang J; Yang R; Li JW; Qiu TT; Luo Y; Lu Q
    World J Gastroenterol; 2022 Jun; 28(21):2350-2360. PubMed ID: 35800178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LI-RADS LR-5 on contrast-enhanced ultrasonography has satisfactory diagnostic specificity for hepatocellular carcinoma: a systematic review and meta-analysis.
    Jin H; Cai Y; Zhang M; Huang L; Bao W; Hu Q; Chen X; Zhou L; Ling W
    Quant Imaging Med Surg; 2023 Feb; 13(2):957-969. PubMed ID: 36819240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Performance of Contrast-enhanced Ultrasound Liver Imaging Reporting and Data System LR-5 in the Diagnosis of Hepatocellular Carcinoma:A Meta-analysis].
    Yan XY; Lü K; Chen TJ; Li JC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Feb; 45(1):57-63. PubMed ID: 36861156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Yang J; Zhang YH; Li JW; Shi YY; Huang JY; Luo Y; Liu JB; Lu Q
    World J Gastroenterol; 2020 Dec; 26(46):7325-7337. PubMed ID: 33362387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.
    van der Pol CB; Lim CS; Sirlin CB; McGrath TA; Salameh JP; Bashir MR; Tang A; Singal AG; Costa AF; Fowler K; McInnes MDF
    Gastroenterology; 2019 Mar; 156(4):976-986. PubMed ID: 30445016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic performance of intravascular perfusion based contrast-enhanced ultrasound LI-RADS in the evaluation of hepatocellular carcinoma.
    Zuo D; Yang K; Wu S
    Clin Hemorheol Microcirc; 2021; 78(4):429-437. PubMed ID: 33867358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can Modifications of LR-M Criteria Improve the Diagnostic Performance of Contrast-Enhanced Ultrasound LI-RADS for Small Hepatic Lesions up to 3 cm?
    Huang W; Wen R; Wu Y; Lin P; Guo D; Peng Y; Liu D; Mou M; Chen F; Huang F; Yang H; He Y
    J Ultrasound Med; 2023 Oct; 42(10):2403-2413. PubMed ID: 37269201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Application of Liver Imaging Reporting and Data System for Characterizing Liver Neoplasms: A Meta-Analysis.
    Li L; Hu Y; Han J; Li Q; Peng C; Zhou J
    Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33671158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Revision of the LR-M Criteria on the Diagnostic Performance of Contrast-Enhanced Ultrasound LI-RADS.
    Ding J; Qin Z; Zhou Y; Zhou H; Zhang Q; Wang Y; Jing X; Wang F
    Ultrasound Med Biol; 2021 Dec; 47(12):3403-3410. PubMed ID: 34598799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.
    Strobel D; Jung EM; Ziesch M; Praktiknjo M; Link A; Dietrich CF; Klinger C; Schultheiß M; Jesper D; Schellhaas B
    Eur Radiol; 2021 Oct; 31(10):7614-7625. PubMed ID: 33855588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Contrast-Enhanced Ultrasound versus Contrast-Enhanced Magnetic Resonance Imaging for the Diagnosis of Focal Liver Lesions Using the Liver Imaging Reporting and Data System.
    Wang JY; Feng SY; Yi AJ; Zhu D; Xu JW; Li J; Cui XW; Dietrich CF
    Ultrasound Med Biol; 2020 May; 46(5):1216-1223. PubMed ID: 32115307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inter-reader reliability of contrast-enhanced ultrasound Liver Imaging Reporting and Data System: a meta-analysis.
    Kang JH; Choi SH; Lee JS; Kim DW; Jang JK
    Abdom Radiol (NY); 2021 Oct; 46(10):4671-4681. PubMed ID: 34156509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS.
    Hu YX; Shen JX; Han J; Mao SY; Mao RS; Li Q; Li F; Guo ZX; Zhou JH
    Front Oncol; 2021; 11():641195. PubMed ID: 33912456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CT and MRI Liver Imaging Reporting and Data System Version 2018 for Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis.
    Lee S; Kim YY; Shin J; Hwang SH; Roh YH; Chung YE; Choi JY
    J Am Coll Radiol; 2020 Oct; 17(10):1199-1206. PubMed ID: 32640250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI.
    Kim YY; An C; Kim S; Kim MJ
    Eur Radiol; 2018 May; 28(5):2038-2046. PubMed ID: 29230525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Performance of CT/MRI Liver Imaging Reporting and Data System v2017 for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Lee S; Kim SS; Roh YH; Choi JY; Park MS; Kim MJ
    Liver Int; 2020 Jun; 40(6):1488-1497. PubMed ID: 32145134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of the Time Difference Method in Identifying Hepatocellular Carcinoma in Current CEUS LR-M Category Nodules.
    Shao LJ; Wang YJ; Yin SS; Jiang BB; Liu YH; Wang JC; Yang W; Wu W; Yan K
    Ultrasound Med Biol; 2024 Apr; 50(4):502-508. PubMed ID: 38246805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.
    Li F; Li Q; Liu Y; Han J; Zheng W; Huang Y; Zheng X; Cao L; Zhou JH
    Eur Radiol; 2020 Jan; 30(1):461-470. PubMed ID: 31297632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of LI-RADS for MRI and CT detection of HCC: A systematic review and diagnostic meta-analysis.
    Liang Y; Xu F; Guo Y; Lai L; Jiang X; Wei X; Wu H; Wang J
    Eur J Radiol; 2021 Jan; 134():109404. PubMed ID: 33276248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.